![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by AFP Staff Writers Beijing (AFP) July 16, 2021
China's President Xi Jinping on Friday promised $3 billion in aid to developing countries to fight Covid-19 at an unprecedented emergency online meeting of APEC heads of state. Xi said the additional funds, which come after a similar pledge in May, were intended to "support Covid-19 response and economic and social recovery in other developing countries," according to the official Xinhua news agency. Appearing via a video-link, Xi added that China has already supplied developing countries wth more than 500 million Covid-19 vaccine doses. New Zealand's Prime Minister Jacinda Ardern was scheduled to host the annual summit of leaders from the 21-nation Asia-Pacific Economic Cooperation (APEC) group in December, but called an additional meeting with less than five days' notice to address urgent issues caused by the global pandemic. US President Joe Biden and Russia's Vladimir Putin are attending the meeting, which began on Friday evening Beijing time. Faced with international criticism over how it handled the initial outbreak in the central city of Wuhan and calls for an international inquiry into the causes of the pandemic, Beijing has been keen to position itself as a saviour for other countries now struggling to control the virus. China, where the coronavirus first surfaced in late 2019, has promised billions of dollars in aid, medical equipment and vaccines to countries around the world in recent months as it brought domestic outbreaks under control.
![]() ![]() BioNTech produces 10 times more antibodies than China's Sinovac Hong Kong (AFP) July 16, 2021 People who received BioNTech's coronavirus vaccine had ten times the amount of antibodies than those given China's Sinovac, a Hong Kong study has shown, adding to growing data on different jabs' effectiveness. The University of Hong Kong (HKU) research, based on a study of 1,442 healthcare workers, was published in Lancet Microbe on Thursday. Researchers said antibodies are not the only measure of a vaccine's success at fighting a particular disease. But they warned that "the difference in c ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |